Activity of epirubicin in combination chemotherapy of advanced ovarian cancer. Results of the South-East European Oncology Group (SEEOG) Study.

Source:http://linkedlifedata.com/resource/pubmed/id/3554083

Download in:

View as

General Info

PMID
3554083